Episode Details
Back to EpisodesOnabotulinumtoxinA and Migraine: Clinical Insights and Recent Evidence
Episode 610
Published 5 months, 3 weeks ago
Description
Drs. Ailani and Dougherty discuss onabotulinumtoxinA, a cornerstone treatment for chronic migraine, which reduces headache days and disability when given regularly with the PREEMPT protocol. They emphasize its unique benefits and how it pairs with CGRP therapies, oral preventives, and lifestyle changes for individualized care.